BR112018017141A2 - método para a imobilização de biomoléculas - Google Patents

método para a imobilização de biomoléculas

Info

Publication number
BR112018017141A2
BR112018017141A2 BR112018017141A BR112018017141A BR112018017141A2 BR 112018017141 A2 BR112018017141 A2 BR 112018017141A2 BR 112018017141 A BR112018017141 A BR 112018017141A BR 112018017141 A BR112018017141 A BR 112018017141A BR 112018017141 A2 BR112018017141 A2 BR 112018017141A2
Authority
BR
Brazil
Prior art keywords
metal surface
immobilization
modified
biomolecules
group
Prior art date
Application number
BR112018017141A
Other languages
English (en)
Inventor
Leenders Frank
Schoeder Heinz
Griessner Matthias
Kraehmer Ralf
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of BR112018017141A2 publication Critical patent/BR112018017141A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
    • B01J19/122—Incoherent waves
    • B01J19/123—Ultraviolet light
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J2219/0873—Materials to be treated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Electromagnetism (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

a invenção está relacionada a um método para a imobilização de biomoléculas que contêm pelo menos um grupo sulfidrila, cujo método compreende o contato de uma superfície metálica modificada com a biomolécula, a irradiação da superfície resultante com radiação uv na presença de um fotoiniciador, em que a referida superfície metálica é modificada com um composto reticulante que compreende um grupo tiol ou ditiol terminal ligado covalentemente à superfície metálica, um grupo espaçador que, na outra extremidade terminal, está carregando uma ligação dupla ou tripla isolada.
BR112018017141A 2016-02-22 2017-02-17 método para a imobilização de biomoléculas BR112018017141A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16156777 2016-02-22
PCT/EP2017/053601 WO2017144359A1 (en) 2016-02-22 2017-02-17 Method for the immobilization of biomolecules

Publications (1)

Publication Number Publication Date
BR112018017141A2 true BR112018017141A2 (pt) 2019-01-02

Family

ID=55405244

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018017141A BR112018017141A2 (pt) 2016-02-22 2017-02-17 método para a imobilização de biomoléculas

Country Status (8)

Country Link
US (1) US10962534B2 (pt)
EP (1) EP3420355A1 (pt)
JP (1) JP7005504B2 (pt)
KR (1) KR20180115276A (pt)
CN (1) CN108885212B (pt)
BR (1) BR112018017141A2 (pt)
CA (1) CA3010905A1 (pt)
WO (1) WO2017144359A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7120547B2 (ja) * 2019-02-22 2022-08-17 国立研究開発法人理化学研究所 物質固定化剤、及び当該物質固定化剤を用いた物質固定化方法
GB202110419D0 (en) * 2021-07-20 2021-09-01 Univ Strathclyde Electrochemical sensor

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5294369A (en) * 1990-12-05 1994-03-15 Akzo N.V. Ligand gold bonding
DE122007000023I1 (de) 1991-07-19 2007-08-09 Univ Queensland St Lucia Impfsstoff gegen Humanes Papillomavirus (typ 18)
DE122007000096I1 (de) 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE122007000090I1 (de) 1993-03-09 2008-03-27 Univ Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen
AUPN015794A0 (en) 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
AU9363798A (en) 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
EP2210945B1 (en) 1998-01-14 2013-06-26 Novartis Vaccines and Diagnostics S.r.l. Neisseria meningitidis antigens
AU761780B2 (en) 1998-05-01 2003-06-12 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
GB9819898D0 (en) 1998-09-11 1998-11-04 Smithkline Beecham Plc New vaccine and method of use
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US6225443B1 (en) 1999-05-19 2001-05-01 Wisconsin Alumni Research Foundation Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
CA2469620A1 (en) 2001-12-12 2003-06-19 Chiron Srl. Immunisation against chlamydia trachomatis
GB0203403D0 (en) 2002-02-13 2002-04-03 Chiron Spa Chlamydia cytotoxic-T cell epitopes
AU2003302235A1 (en) 2002-12-03 2004-06-23 Sloan-Kettering Institute For Cancer Research Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
JP4896715B2 (ja) 2003-06-26 2012-03-14 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫原性組成物
US7396676B2 (en) 2005-05-31 2008-07-08 Agilent Technologies, Inc. Evanescent wave sensor with attached ligand
EP1826564B1 (en) 2006-02-27 2013-03-27 FUJIFILM Corporation A method for producing a biosensor
JP2011503517A (ja) 2006-11-13 2011-01-27 アテリス テクノロジーズ，エルエルシー 農薬バイオマーカー
CA2675257A1 (en) 2007-01-12 2008-08-21 The University Of Western Ontario Hiv combination vaccine and prime boost method
EA201000829A1 (ru) 2007-12-21 2011-06-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина
US20110008417A1 (en) 2008-01-16 2011-01-13 Opal Therapeutics Pty Ltd Immunomodulating compositions and uses therefor
WO2011041586A1 (en) * 2009-09-30 2011-04-07 Virogenomics, Inc. Electromagnetic detection of analytes
WO2012079030A2 (en) 2010-12-10 2012-06-14 The Regents Of The University Of California Bioconjugation using bifunctional linkers
JP2012233878A (ja) 2011-04-22 2012-11-29 Sysmex Corp 被検物質の電気化学的検出方法
US9988433B2 (en) 2013-03-14 2018-06-05 Mosaic Biosciences, Inc. Covalent modification of biological macromolecules
CN104597230B (zh) 2015-01-29 2017-04-05 国家纳米科学中心 一种功能高分子薄膜、制备方法及其应用

Also Published As

Publication number Publication date
JP2019505808A (ja) 2019-02-28
KR20180115276A (ko) 2018-10-22
CN108885212A (zh) 2018-11-23
US20170241998A1 (en) 2017-08-24
US10962534B2 (en) 2021-03-30
WO2017144359A1 (en) 2017-08-31
JP7005504B2 (ja) 2022-01-21
EP3420355A1 (en) 2019-01-02
CA3010905A1 (en) 2017-08-31
CN108885212B (zh) 2022-05-31

Similar Documents

Publication Publication Date Title
CL2020003409A1 (es) Moléculas de unión específicas para cd73 y métodos de fabricación de las mismas (divisional de la solicitud no. 201701154)
CL2021001179A1 (es) Anticuerpos específicos para tl1a y ácidos nucleicos que los codifican (divisional de la solicitud no. 201801596).
BR112018010660A2 (pt) modificação de coeficientes de transformada para unidades de transformada não-quadradas na codificação de vídeo?
GT201800090A (es) Anticuerpos que se unen específicamente a pd-1 y sus usos
ECSP20024555A (es) Anticuerpos especificos para cd47 y pd-l1
BR112016020065A2 (pt) sítios específicos para modificar anticorpos para fazer imunoconjugados
CO2018011364A2 (es) Anticuerpos anti-il-33, composiciones, métodos y usos de los mismos
BR112017009728A2 (pt) anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio
BR112019000071A2 (pt) conjugados adjuvantes de anticorpo
BR112017013240A2 (pt) produtos farmacêuticos e composições líquidas estáveis de anticorpos de il-17, processo para a redução da oxidação do secukinumab, uso de um anticorpo de il-17 e kit
CL2020000937A1 (es) Anticuerpo multiespecífico.
BR112016023417A2 (pt) predição in vitro de meia-vida in vivo
CY1123784T1 (el) Αντισωματα enanti-tnf αλφα και λειτουργικα θραυσματα αυτων
BR112017007990A2 (pt) processo e aparelho para aplicar um elemento de redução de ruído a um pneu para rodas de veículo.
BR112019004995A2 (pt) anticorpo que se liga especificamente a pd-1 e fragmento funcional do mesmo
BR112019008225A2 (pt) spray de aerossol contendo espécies de bactérias viáveis
BR112017012515A2 (pt) membros vinculantes para c-maf humano
BR112019004727A2 (pt) método e sistema para revestimento hidrofóbico de chips microfluídicos
BR112014005678A2 (pt) sistema de revestimento/selante, dispersão resinosa aquosa e método para eletrorrevestir um substrato eletricamente condutivo
BR112018017141A2 (pt) método para a imobilização de biomoléculas
BR112019003361A2 (pt) métodos e usos de frações de material orgânico dissolvido para ligação a íons metálicos
CL2019000780A1 (es) Partícula que contiene al menos una sustancia volátil y proceso para su preparación.
BR112022003282A2 (pt) Glicovariantes de igm
BR112018010669A2 (pt) anticorpo anti-pcsk9 e utilização do mesmo
BR112018009837A2 (pt) composição catalítica e composição curável

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2762 DE 12-12-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.